129 related articles for article (PubMed ID: 30847188)
1. The first reported case of vincristine-induced unilateral vocal cord palsy in an adult patient with HIV-associated Burkitt-like lymphoma being treated with dose-escalated R-EPOCH.
Rahmat LT; Brandt PH; Ali SS
Clin Case Rep; 2019 Feb; 7(2):272-274. PubMed ID: 30847188
[TBL] [Abstract][Full Text] [Related]
2. Vincristine-induced vocal cord palsy and successful re-treatment in a patient with diffuse large B cell lymphoma: a case report.
Samoon Z; Shabbir-Moosajee M
BMC Res Notes; 2014 May; 7():318. PubMed ID: 24886197
[TBL] [Abstract][Full Text] [Related]
3. Vincristine-Induced Bilateral Vocal Cord Palsy in an Adult Male With Diffuse Large B-Cell Lymphoma.
Leedman S; Flukes S
Cureus; 2021 Oct; 13(10):e18591. PubMed ID: 34765356
[TBL] [Abstract][Full Text] [Related]
4. Vincristine-induced vocal cord palsy: case report and review of the literature.
Latiff ZA; Kamal NA; Jahendran J; Alias H; Goh BS; Syed Zakaria SZ; Jamal R
J Pediatr Hematol Oncol; 2010 Jul; 32(5):407-10. PubMed ID: 20505534
[TBL] [Abstract][Full Text] [Related]
5. Low-dose vincristine-associated bilateral vocal cord paralysis.
Ryan SP; DelPrete SA; Weinstein PW; Erichson RB; Bar MH; Lo KM; Cohen NS; Tepler I
Conn Med; 1999 Oct; 63(10):583-4. PubMed ID: 10578547
[TBL] [Abstract][Full Text] [Related]
6. A case report of acquired immunodeficiency syndrome (AIDS)-related refractory Burkitt lymphoma got complete remission by multidisciplinary and multi-target combined therapy.
Zhang R; Sun J
Transl Cancer Res; 2022 Jun; 11(6):1806-1812. PubMed ID: 35836543
[TBL] [Abstract][Full Text] [Related]
7. Chronic vocal cord palsy in Thuringia, Germany: a population-based study on epidemiology and outcome.
Djugai S; Boeger D; Buentzel J; Esser D; Hoffmann K; Jecker P; Mueller A; Radtke G; Bohne S; Finkensieper M; Volk GF; Guntinas-Lichius O
Eur Arch Otorhinolaryngol; 2014 Feb; 271(2):329-35. PubMed ID: 23974329
[TBL] [Abstract][Full Text] [Related]
8. Unilateral Vocal Cord Motion Impairment After 1 Dose of Vincristine: Case Report and Literature Review.
Aaron H; Azadarmaki R; Lango MN
Am J Ther; 2016; 23(2):e621-3. PubMed ID: 25738569
[TBL] [Abstract][Full Text] [Related]
9. Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma.
Roschewski M; Dunleavy K; Abramson JS; Powell BL; Link BK; Patel P; Bierman PJ; Jagadeesh D; Mitsuyasu RT; Peace D; Watson PR; Hanna WT; Melani C; Lucas AN; Steinberg SM; Pittaluga S; Jaffe ES; Friedberg JW; Kahl BS; Little RF; Bartlett NL; Fanale MA; Noy A; Wilson WH
J Clin Oncol; 2020 Aug; 38(22):2519-2529. PubMed ID: 32453640
[TBL] [Abstract][Full Text] [Related]
10. Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075).
Ramos JC; Sparano JA; Rudek MA; Moore PC; Cesarman E; Reid EG; Henry D; Ratner L; Aboulafia D; Lee JY; Ambinder RF; Mitsuyasu R; Noy A
Clin Lymphoma Myeloma Leuk; 2018 Mar; 18(3):180-190.e2. PubMed ID: 29426719
[TBL] [Abstract][Full Text] [Related]
11. An Advanced AIDS Patient With CD4 <20 and Plasmablastic Lymphoma Achieving Complete Response With the V-EPOCH Regimen.
Nelson B; Hong A; Iqbal F; Venkatesan R
Cureus; 2020 Jun; 12(6):e8641. PubMed ID: 32685310
[TBL] [Abstract][Full Text] [Related]
12. Low-intensity therapy in adults with Burkitt's lymphoma.
Dunleavy K; Pittaluga S; Shovlin M; Steinberg SM; Cole D; Grant C; Widemann B; Staudt LM; Jaffe ES; Little RF; Wilson WH
N Engl J Med; 2013 Nov; 369(20):1915-25. PubMed ID: 24224624
[TBL] [Abstract][Full Text] [Related]
13. Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia.
Cortes J; Thomas D; Rios A; Koller C; O'Brien S; Jeha S; Faderl S; Kantarjian H
Cancer; 2002 Mar; 94(5):1492-9. PubMed ID: 11920506
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Oncology Patients With Vincristine-Induced Recurrent Laryngeal Nerve Palsy: Two Case Reports and a Brief Review of Literature.
Tay SY; Foster J; Heczey A; Sitton M
Ear Nose Throat J; 2021 Dec; 100(10):NP459-NP463. PubMed ID: 32425060
[TBL] [Abstract][Full Text] [Related]
15. Vincristine-induced recurrent laryngeal nerve paralysis.
Annino DJ; MacArthur CJ; Friedman EM
Laryngoscope; 1992 Nov; 102(11):1260-2. PubMed ID: 1405987
[TBL] [Abstract][Full Text] [Related]
16. Bilateral vocal cord paralysis following treatment with vincristine.
Naithani R; Dolai TK; Kumar R
Indian Pediatr; 2009 Jan; 46(1):68-9. PubMed ID: 19179723
[TBL] [Abstract][Full Text] [Related]
17. Vincristine-induced vocal cord paresis and paralysis in children.
Zavala H; Roby BB; Day A; Bostrom B; Sidman J; Chinnadurai S
Int J Pediatr Otorhinolaryngol; 2019 Aug; 123():1-4. PubMed ID: 31048222
[TBL] [Abstract][Full Text] [Related]
18. Vocal cord palsy after vincristine treatment in a child and the inefficacy of glutamic acid in the prevention of relapse: a case report.
Farruggia P; Tropia S; Cannella S; Bruno G; Oddo G; D'Angelo P
J Med Case Rep; 2012 May; 6():128. PubMed ID: 22584039
[TBL] [Abstract][Full Text] [Related]
19. Dose-adjusted EPOCH-R is not superior to sequential R-CHOP/R-ICE as a frontline treatment for newly diagnosed primary mediastinal B-cell lymphoma: Results of a bi-center retrospective study.
Morgenstern Y; Aumann S; Goldschmidt N; Gatt ME; Nachmias B; Horowitz NA
Cancer Med; 2021 Dec; 10(24):8866-8875. PubMed ID: 34816617
[TBL] [Abstract][Full Text] [Related]
20. Vocal cord palsy after anterior cervical spine surgery: a qualitative systematic review.
Tan TP; Govindarajulu AP; Massicotte EM; Venkatraghavan L
Spine J; 2014 Jul; 14(7):1332-42. PubMed ID: 24632183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
